Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Breast Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 66 articles: HTML format

Single Articles

June 2025
1. IYER P
   Locally Advanced Breast Cancer: A Systemic Disease with a Locoregional Symptom Burden. Is it Time to Challenge the "No Local Treatment" Stereotype?
   Int J Radiat Oncol Biol Phys. 2025;122:292-293.
   PubMed    
   
   
   
2. NAOUM GE, Dobinda K, Yalamanchili A, Ho A, et al
   Protons Versus Photons Postmastectomy Radiation Therapy Effects on Breast Reconstruction Outcomes and Dosimetry Analysis.
   Int J Radiat Oncol Biol Phys. 2025;122:249-266.
   PubMed     Abstract available
   
   
   May 2025
3. SHI W, Zhang L, Li Z, Zhao X, et al
   Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients With Breast Cancer After Reconstructive Surgery: A Prospective, Longitudinal Study.
   Int J Radiat Oncol Biol Phys. 2025 May 6:S0360-3016(25)00350.
   PubMed     Abstract available
   
   
   
4. POPPE MM, Boucher K, Gaffney DK, Brownson KE, et al
   NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer.
   Int J Radiat Oncol Biol Phys. 2025 May 2:S0360-3016(25)00348.
   PubMed     Abstract available
   
   
   
5. KIM N, Kim SS, Cho WK, Park W, et al
   Concurrent Versus Sequential Adjuvant Capecitabine-Based Chemoradiation in Residual Triple-Negative Breast Cancer After Neoadjuvant-Chemotherapy: A Multicenter Comparative Study.
   Int J Radiat Oncol Biol Phys. 2025;122:72-83.
   PubMed     Abstract available
   
   
   April 2025
6. NAOUM GE, Ababneh HS, Niemierko A, Salama L, et al
   Impact of Prepectoral Implant Placement and Radiation Modalities (Protons/Photons/Dosimetry) in Mastectomy Patients Undergoing Immediate Single Stage Direct-to-Implant Breast Reconstruction.
   Int J Radiat Oncol Biol Phys. 2025;121:1156-1167.
   PubMed     Abstract available
   
   
   March 2025
7. TAGHIAN AG, Naoum GE, Braunstein LZ, Niemierko A, et al
   Defining the Optimal Dose for 3-Dimensional Conformal Accelerated Partial Breast Irradiation: 15-Year Follow-Up of a Dose-Escalation Trial.
   Int J Radiat Oncol Biol Phys. 2025;121:900-909.
   PubMed     Abstract available
   
   
   
8. BRAUNSTEIN LZ, Boe L, Mueller B, Obrien DR, et al
   Accelerated Partial Breast Irradiation for Early-Stage Invasive Lobular Carcinoma.
   Int J Radiat Oncol Biol Phys. 2025;121:894-899.
   PubMed     Abstract available
   
   
   
9. YANG K, Zhang Y, Li S, Chen L, et al
   Multimodal Photoacoustic/Elastography Imaging for the Detection of Acute Radiation Dermatitis in Breast Radiation Therapy.
   Int J Radiat Oncol Biol Phys. 2025;121:910-917.
   PubMed     Abstract available
   
   
   
10. DZHUGASHVILI M, Serradilla A, Fernandez-Ibiza J, Garcia G, et al
    Ultrahypofractionation and Simultaneous Integrated Boost in Breast Cancer: Early Side Effects Analysis.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00141.
    PubMed     Abstract available
    
    
    
11. BAI J, Gong C, Hu YJ, Bruner DW, et al
    Skin Microbiome, Inflammation, and Skin Toxicities in Women With Breast Cancer Receiving Moderately Hypofractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 8:S0360-3016(25)00194.
    PubMed     Abstract available
    
    
    
12. TELLO VALVERDE CP, Bakker A, Kok HP, Kolff MW, et al
    The Probability of Locoregional Control in Patients With Locoregional Recurrent Breast Cancer Treated With Postoperative Reirradiation and Hyperthermia (RADHY): A Continuous Thermal Dose-effect Relationship.
    Int J Radiat Oncol Biol Phys. 2025 Mar 7:S0360-3016(25)00176.
    PubMed     Abstract available
    
    
    
13. SHAITELMAN SF
    ABLATIVE Radiation Therapy for Breast Cancer: The Time Has Come for Innovation.
    Int J Radiat Oncol Biol Phys. 2025;121:623-625.
    PubMed    
    
    
    
14. VINASCO-SANDOVAL T, Moratille S, Crechet F, Mesloub Y, et al
    Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility After Radiation Therapy and Promoter of Transforming Growth Factor Beta1-Driven Fibrosis.
    Int J Radiat Oncol Biol Phys. 2025;121:783-797.
    PubMed     Abstract available
    
    
    
15. CIVIL YA, Vasmel JE, Charaghvandi RK, Houweling AC, et al
    Preoperative Magnetic Resonance Guided Single-Dose Partial Breast Irradiation: 5-Year Results of the Prospective Single-Arm ABLATIVE Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:613-622.
    PubMed     Abstract available
    
    
    
16. MA J, Shah R, Bell AC, McDermott N, et al
    Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors.
    Int J Radiat Oncol Biol Phys. 2025;121:768-779.
    PubMed     Abstract available
    
    
    February 2025
17. SALARI K, Lee JS, Mumaw DA, Almahariq MF, et al
    Regional Near-surface Dose Predicts Moist Desquamation and Implant Failure in Patients Receiving Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Feb 24:S0360-3016(25)00148.
    PubMed     Abstract available
    
    
    
18. REVERBERI C, Facondo G, Prisco A, Ceschia T, et al
    Pre-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer Patients with Gammapod Technology: Pathological Findings and Ki-67 Evaluation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00152.
    PubMed     Abstract available
    
    
    
19. MUTTER RW, Golafshar MA, Buras MR, Comstock BP, et al
    Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:352-364.
    PubMed     Abstract available
    
    
    
20. GLICKSMAN RM, Raman S, Ye XY, Bedard PL, et al
    The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:292-306.
    PubMed     Abstract available
    
    
    
21. DECKER SM, Bruza P, Zhang R, Pogue BW, et al
    Visual Dose Monitoring for Whole Breast Radiation Therapy Treatments via Combined Cherenkov Imaging and Scintillation Dosimetry.
    Int J Radiat Oncol Biol Phys. 2025;121:365-374.
    PubMed     Abstract available
    
    
    January 2025
22. MORRIS AD, Hanes DA, Kaplan HG
    Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2025 Jan 24:S0360-3016(24)03705.
    PubMed     Abstract available
    
    
    
23. CAO J, Yassa M, Bolivar CHA, Dahn H, et al
    Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective.
    Int J Radiat Oncol Biol Phys. 2025 Jan 10:S0360-3016(25)00022.
    PubMed     Abstract available
    
    
    
24. ROBERTI S, Russell NS, Pfeiffer RM, Krul IM, et al
    Radiation doses to the breast and predicted breast cancer risk among patients treated for Hodgkin lymphoma with modern radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jan 8:S0360-3016(24)03775.
    PubMed     Abstract available
    
    
    
25. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    PubMed     Abstract available
    
    
    
26. SHAITELMAN SF, Le-Petross H, Raso MG, Swanson DM, et al
    PRECISE: Preoperative Radiation Therapy to Elicit Critical Immune Stimulating Effects-A Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:90-96.
    PubMed     Abstract available
    
    
    December 2024
27. LEE J, Byun HK, Kim YT, Shin J, et al
    A study on BReast cancer patient care using chAtbot and Video Education for radiation therapy (BRAVE): A randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Dec 26:S0360-3016(24)03732.
    PubMed     Abstract available
    
    
    
28. DENG XW, Zhao HM, Jia LC, Li JN, et al
    Prior Knowledge-Guided U-Net for Automatic CTV Segmentation in Postmastectomy Radiotherapy of Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Dec 10:S0360-3016(24)03711.
    PubMed     Abstract available
    
    
    
29. LOAP P, Kirova Y, Braunstein LZ
    Honing Locoregional Therapy for Breast Cancer: Refinement of Surgical and Radiotherapeutic Management.
    Int J Radiat Oncol Biol Phys. 2024;120:1199-1204.
    PubMed    
    
    
    November 2024
30. LEE SF, Yip PL, Spencer S, Ho H, et al
    StrataXRT and Mepitel Film for preventing post-mastectomy acute radiation dermatitis in breast cancer: an intra-patient non-inferiority randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Nov 26:S0360-3016(24)03656.
    PubMed     Abstract available
    
    
    
31. CORRIGAN KL, Bankston ME, Holliday EB, Shaitelman SF, et al
    Disease Site Specialization in the Academic Radiation Oncology Workforce: Evidence of Gender Differences.
    Int J Radiat Oncol Biol Phys. 2024;120:936-939.
    PubMed     Abstract available
    
    
    
32. COSTA IM, Firth G, Kim J, Banu A, et al
    In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and beta Particle-Emitting Radionuclides and External Beam Radiation for Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2024;120:1124-1134.
    PubMed     Abstract available
    
    
    
33. LEE TH, Kim N, Kim EK, Ahn JS, et al
    Significant Influence of Cardiac Radiation Dose on the Risk of Cardiotoxicity in Patients Receiving Adjuvant Trastuzumab and Radiation Therapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03583.
    PubMed     Abstract available
    
    
    
34. JACOMINA LE, Swanson DM, Mitchell MP, Woodward WA, et al
    Outcomes After Palliative Radiotherapy in Patients with Symptomatic Locoregionally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03637.
    PubMed     Abstract available
    
    
    October 2024
35. REDDY JP, Sherry AD, Fellman B, Liu S, et al
    Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2024 Oct 30:S0360-3016(24)03522.
    PubMed     Abstract available
    
    
    
36. HEALY E, Bazan JG
    A Boost in the Wrong Direction? Rethinking Escalated Approaches for Ductal Carcinoma In Situ.
    Int J Radiat Oncol Biol Phys. 2024;120:317.
    PubMed    
    
    
    
37. SHAH C, Tendulkar R
    The Role of Boost in Ductal Carcinoma In Situ: A Partial Answer?
    Int J Radiat Oncol Biol Phys. 2024;120:316.
    PubMed    
    
    
    
38. BASREE MM, Blitzer GC
    Boosting the Odds: Navigating Fraction Options in the Ductal Carcinoma In Situ Odyssey.
    Int J Radiat Oncol Biol Phys. 2024;120:315.
    PubMed    
    
    
    September 2024
39. KIM N, Park W, Kim H, Cho WK, et al
    Patient-reported outcomes between whole-breast plus regional irradiation and whole-breast irradiation only in pN1 breast cancer after breast conserving surgery and taxane-based chemotherapy: A randomized phase 3 clinical trial (KROG 17-01).
    Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03392.
    PubMed     Abstract available
    
    
    
40. YEHIA ZA, Sherwani Z, Chakraborty M, Ohri N, et al
    First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Sep 4:S0360-3016(24)03320.
    PubMed     Abstract available
    
    
    
41. RODIN D, Glicksman RM, Hepel JT, Huber K, et al
    Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice.
    Int J Radiat Oncol Biol Phys. 2024 Sep 3:S0360-3016(24)03293.
    PubMed     Abstract available
    
    
    August 2024
42. SPEERS C, Anderson B
    Can Less Be More? Evolving Strategies for Therapy De-escalation in Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2024;119:1327-1330.
    PubMed    
    
    
    
43. LEE BM, Kim JS, Chang Y, Choi SH, et al
    Experience of Implementing Deep Learning-Based Automatic Contouring in Breast Radiation Therapy Planning: Insights From Over 2000 Cases.
    Int J Radiat Oncol Biol Phys. 2024;119:1579-1589.
    PubMed     Abstract available
    
    
    
44. FAERMANN R, Sklair-Levy M, Shalmon A, Halshtok Neiman O, et al
    Incidental Axillary Lymphadenopathy Found on Radiation Planning Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;119:1464-1470.
    PubMed     Abstract available
    
    
    
45. MARKAN U, Baker K, Eggleston C, Cheston SB, et al
    Psychosocial Factors That Influence a Woman's Decision to Enroll in a Clinical Trial: Implications on How to Improve Clinical Trial Enrollment Among Black Women.
    Int J Radiat Oncol Biol Phys. 2024;119:1347-1356.
    PubMed     Abstract available
    
    
    July 2024
46. BEYDOUN H, Griffith KA, Jagsi R, Burmeister JW, et al
    Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
    Int J Radiat Oncol Biol Phys. 2024;119:1092-1098.
    PubMed     Abstract available
    
    
    
47. ASHA W, Al-Hilli Z, Djohan R, Budd GT, et al
    Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast.
    Int J Radiat Oncol Biol Phys. 2024;119:1082-1085.
    PubMed     Abstract available
    
    
    
48. HEPEL JT, Leonard KL, Yashar CM, Einck JP, et al
    Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2024;119:878-883.
    PubMed     Abstract available
    
    
    June 2024
49. YIT LFN, Quek ZHS, Tan JYT, Tan BF, et al
    Curative Approaches for Metaplastic Breast Cancer: A Retrospective Cohort Outcome Review.
    Int J Radiat Oncol Biol Phys. 2024 Jun 29:S0360-3016(24)00751.
    PubMed     Abstract available
    
    
    
50. ZHOU YY, Li YN, Xu JF, Chen B, et al
    Rapid Selection of Patients Suitable for Deep Inspiration Breath-Hold Using an Automatic Delineating System and RapidPlan Model in Left Breast Cancer Patients undergoing Adjuvant Radiotherapy with IMRT.
    Int J Radiat Oncol Biol Phys. 2024 Jun 26:S0360-3016(24)00739.
    PubMed     Abstract available
    
    
    
51. LO AC, Ronckers C, Aznar MC, Avanzo M, et al
    Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:549-559.
    PubMed     Abstract available
    
    
    May 2024
52. HAHN EA, Pugh SL, Lu HL, Vela AM, et al
    Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 13:S0360-3016(24)00436.
    PubMed     Abstract available
    
    
    
53. KOLEOSO O, Toumbacaris N, Brogi E, Zhang Z, et al
    The presence of extensive lymphovascular invasion (LVI) is associated with higher risks of local-regional recurrence compared to usual LVI in curatively treated breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 May 4:S0360-3016(24)00625.
    PubMed     Abstract available
    
    
    April 2024
54. YONEYAMA M, Zormpas-Petridis K, Robinson R, Sobhani F, et al
    Longitudinal assessment of tumor-infiltrating lymphocytes in primary breast cancer following neoadjuvant radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00566.
    PubMed     Abstract available
    
    
    
55. KIM E, Yoo JS, Kim YJ, Joo J, et al
    Toxicity evaluation of dose-escalation in hypofractionated regional nodal irradiation for breast cancer: a retrospective study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00513.
    PubMed     Abstract available
    
    
    
56. ROGE M, Kirova Y, Leveque E, Guigo M, et al
    Impact of radiation therapy modalities on loco-regional control in inflammatory breast cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 13:S0360-3016(24)00506.
    PubMed     Abstract available
    
    
    
57. LOVING BA, Almahariq MF, Sivapalan S, Levitin R, et al
    Newly Diagnosed Mental Health Disorders in Patients with Breast Cancer Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 4:S0360-3016(24)00445.
    PubMed     Abstract available
    
    
    
58. KIROVA YM, Loap P
    Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions.
    Int J Radiat Oncol Biol Phys. 2024;118:1402-1403.
    PubMed    
    
    
    
59. KHAN AJ, Marine CB, Flynn J, Tyagi N, et al
    A Phase II Study Evaluating the Effect of Intensity-Modulated Post-Mastectomy Radiation Therapy on Implant Failure Rates in Breast Cancer Patients with Immediate, 2-Stage Implant Reconstruction, with an MRI imaging correlative substudy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00451.
    PubMed     Abstract available
    
    
    March 2024
60. SHEVA K, Chowdhury SR, Kravchenko-Balasha N, Meirovitz A, et al
    Molecular changes in breast cancer induced by radiation therapy.
    Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00435.
    PubMed     Abstract available
    
    
    
61. SILVERWOOD S, Lichter K, Conway A, Drew T, et al
    Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024;118:891-899.
    PubMed     Abstract available
    
    
    
62. LAUGHLIN BS, Corbin KS, Toesca DAS, Thorpe CS, et al
    Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2024;118:1049-1059.
    PubMed     Abstract available
    
    
    
63. GRENDAROVA P, Roumeliotis M, Quirk S, Phan T, et al
    Accelerated Partial Breast Irradiation Using 5 Daily Fractions: A Prospective, Phase 2, Multicenter Trial of Cosmetic Outcomes and Toxicity-ACCEL Final Results.
    Int J Radiat Oncol Biol Phys. 2024;118:1041-1048.
    PubMed     Abstract available
    
    
    
64. BEHZADI ST, Moser R, Kiesl S, Nano J, et al
    Tumor Contact with Internal Mammary Perforator Vessels as Risk Factor for Gross Internal Mammary Lymph Node Involvement in Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Mar 6:S0360-3016(24)00339.
    PubMed     Abstract available
    
    
    
65. WU VS, Khlopin M, Chadha M, Smith-Graziani DJ, et al
    Out-of-pocket cost modeling of adjuvant antiestrogen and radiation therapy after lumpectomy for early-stage breast cancer across Medicaid and Medicare plans.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00351.
    PubMed     Abstract available
    
    
    December 2023
66. PATEL TA, Jain B, Vapiwala N, Chino F, et al
    Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08173.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.